These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 388682)

  • 1. Inhibition of Haemophilus vaginalis (Corynebacterium vaginale) by metronidazole, tetracycline, and ampicillin.
    Ralph ED; Austin TW; Pattison FL; Schieven BC
    Sex Transm Dis; 1979; 6(3):199-202. PubMed ID: 388682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole in treatment against Haemophilus vaginalis (Corynebacterium vaginale).
    Ralph ED; Amatnieks YE
    Antimicrob Agents Chemother; 1980 Jul; 18(1):101-4. PubMed ID: 6968175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of 5 new quinolones against Gardnerella vaginalis].
    Lefevre JC; Gaubert E; Lareng MB
    Pathol Biol (Paris); 1989 May; 37(5):394-6. PubMed ID: 2550875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.
    Ralph ED; Amatnieks YE
    Sex Transm Dis; 1980; 7(4):157-60. PubMed ID: 6779387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of Haemophilus vaginalis (Corynebacterium vaginale) to 21 antibiotics.
    McCarthy LR; Mickelsen PA; Smith EG
    Antimicrob Agents Chemother; 1979 Aug; 16(2):186-9. PubMed ID: 314776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of Gardnerella vaginalis to antibiotics. Study of 40 strains isolated at the Purpan University Hospital Center of Toulouse].
    Lefevre JC; Prere MF; Lareng MB
    Pathol Biol (Paris); 1983 Jun; 31(6):533-5. PubMed ID: 6348664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole metabolite and Gardnerella vaginalis (Corynebacterium vaginale).
    Baldson MJ; Jackson D
    Lancet; 1981 May; 1(8229):1112. PubMed ID: 6112482
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis.
    Easmon CS; Ison CA; Kaye CM; Timewell RM; Dawson SG
    Br J Vener Dis; 1982 Aug; 58(4):246-9. PubMed ID: 6980684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Gardnerella vaginalis to metronidazole, its bioactive metabolites, and tinidazole.
    Bannatyne RM; Jackowski J; Cheung R; Biers K
    Am J Clin Pathol; 1987 May; 87(5):640-1. PubMed ID: 3495168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative antimicrobial activity of metronidazole and the hydroxy metabolite against Gardnerella vaginalis.
    Ralph ED
    Scand J Infect Dis Suppl; 1983; 40():115-20. PubMed ID: 6607518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Gardnerella vaginalis to thiamphenicol: clinical experience with nonspecific vaginitis.
    Hubrechts JM; Vanhoof RL; Daems A; Butzler JP
    Sex Transm Dis; 1984; 11(4 Suppl):456-9. PubMed ID: 6335301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting isolation and identification of Haemophilus vaginalis (Corynebacterium vaginale).
    Bailey RK; Voss JL; Smith RF
    J Clin Microbiol; 1979 Jan; 9(1):65-71. PubMed ID: 372217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of Gardnerella vaginalis to vaginal epithelial cells: variables affecting adhesion and inhibition by metronidazole.
    Peeters M; Piot P
    Genitourin Med; 1985 Dec; 61(6):391-5. PubMed ID: 3910547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
    Weber P; Dubois S; Boussougant Y
    J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Haemophilus vaginalis (Corynebacterium vaginale) to oleandomycin and spectinomycin.
    Virtanen S
    Pathol Microbiol (Basel); 1975; 42(1):36-41. PubMed ID: 125402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scanning electron microscopic examination of Bacteroides fragilis and Gardnerella vaginalis after exposure to concentration gradients of metronidazole and tinidazole.
    Skarin A; Mårdh PA
    Scand J Infect Dis Suppl; 1981; 26():54-9. PubMed ID: 6972572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibilities of Gardnerella vaginalis.
    Kharsany AB; Hoosen AA; Van den Ende J
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2733-5. PubMed ID: 8109944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
    Shanker S; Toohey M; Munro R
    Eur J Clin Microbiol; 1982 Oct; 1(5):298-300. PubMed ID: 6223813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corynebacterium vaginale and vaginitis: a controlled trial of treatment.
    Balsdon MJ; Taylor GE; Pead L; Maskell R
    Lancet; 1980 Mar; 1(8167):501-3. PubMed ID: 6102231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Corynebacterium vaginale by metronidazole.
    Smith RF; Dunkelberg WE
    Sex Transm Dis; 1977; 4(1):20-1. PubMed ID: 867202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.